Ross Moat sold $2.3M of Kiniksa Pharmaceuticals International (KNSA)

Executed Apr 29 2025, disclosed May 1 2025, 2 days later.

Value, as filed

$2.3M

87,269 sh across 2 lots

Executed

Apr 29 2025

the trade date, as filed

Disclosed

May 1 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Ross Moat CHIEF OPERATING OFFICER profile →

Ross Moat (CHIEF OPERATING OFFICER) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $115K of KNSA (2,367 sh × $48.58, as filed), executed Apr 6.

The name

KNSA

Kiniksa Pharmaceuticals International, plc KNSA · Healthcare · 68 filings in 24 months ticker →

Healthcare · Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Ross Moat in KNSA

KNSASALE Kiniksa Pharmaceuticals International, plc $115K
2,367 sh × $48.58
Exec Apr 6
Filed Apr 8 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $124K
3,523 sh × $35.31
Exec Sep 4 2025
Filed Sep 8 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $801K
27,594 sh × $29.02
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $283K
10,122 sh across 2 lots
Exec May 2 2025
Filed May 5 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $370K
18,259 sh × $20.29
Exec Apr 21 2025
Filed Apr 23 2025 · 5:30 PM ET